Effects of Resveratrol on Vitrified Porcine Oocytes

Oxidative Medicine and Cellular Longevity - Tập 2013 - Trang 1-7 - 2013
Elisa Giaretta1, Marcella Spinaci1, Diego Bucci1, Carlo Tamanini1, Giovanna Galeati1
1Dipartimento di Scienze Mediche Veterinarie (DIMEVET), Università di Bologna, Via Tolara di Sopra 50, 40064 Ozzano dell’Emilia, Bologna, Italy

Tóm tắt

Vitrified MII porcine oocytes are characterized by reduced developmental competence, associated with the activation of the apoptotic pathway. Resveratrol (R), a polyphenolic compound present in several vegetal sources, has been reported to exert, among all its other biological effects, an antiapoptotic one. The aim of this study was to determine the effects of R (2 µM) on the apoptotic status of porcine oocytes vitrified by Cryotop method, evaluating phosphatidylserine (PS) exteriorization and caspases activation. R was added during IVM (A); 2 h postwarming incubation (B); vitrification/warming and 2 h postwarming incubation (C); all previous phases (D). Data on PS exteriorization showed, in each treated group, a significantly higher (P<0.05) percentage of live nonapoptotic oocytes as compared with CTR; moreover, the percentage of live apoptotic oocytes was significantly (P<0.05) lower in all R-treated groups relative to CTR. The results on caspase activation showed a tendency to an increase of viable oocytes with inactive caspases in B, C, and D, while a significant (P<0.05) increase in A compared to CTR was recorded. These data demonstrate that R supplementation in various phases of IVM and vitrification/warming procedure can modulate the apoptotic process, improving the resistance of porcine oocytes to cryopreservation-induced damage.

Từ khóa


Tài liệu tham khảo

10.1186/1757-2215-6-30

10.1016/j.cryobiol.2010.05.002

10.1016/j.theriogenology.2012.06.008

10.1016/j.cryobiol.2005.08.002

10.1016/j.theriogenology.2006.09.014

10.1016/j.ejogrb.2013.05.004

10.1016/j.theriogenology.2011.08.028

10.1111/j.1439-0531.2007.00899.x

10.1046/j.1439-0531.2001.00248.x

10.1016/j.anireprosci.2011.07.010

10.1016/j.anireprosci.2012.08.020

10.1095/biolreprod.108.070235

10.1016/j.fertnstert.2010.01.043

10.1016/j.anireprosci.2006.06.020

10.1262/jrd.11-140N

10.1016/j.cryobiol.2007.06.008

10.1007/s10495-005-0367-8

10.1016/j.bbamcr.2012.06.019

1992, Journal of Immunology, 148, 2207, 10.4049/jimmunol.148.7.2207

10.1006/bbrc.1998.8663

2001, Journal of Cell Biology, 155, 649

2002, Human Reproduction, 17, 2686, 10.1093/humrep/17.10.2686

10.1016/j.theriogenology.2008.01.005

10.1016/j.theriogenology.2010.04.002

Journal of Veterinary Medical Science, 75, 1279

10.1016/j.theriogenology.2012.01.024

10.1002/iub.47

10.1089/ars.2008.2412

10.1095/biolreprod57.1.49

2005, Reproductive BioMedicine Online, 11, 300, 10.1016/S1472-6483(10)60837-1

2005, Reproductive BioMedicine Online, 11, 608, 10.1016/S1472-6483(10)61169-8

2012

1999, Journal of Immunology, 163, 4115, 10.4049/jimmunol.163.8.4115

2000, Cell Death and Differentiation, 7, 282, 10.1038/sj.cdd.4400646

10.1016/j.vetimm.2013.02.003

10.1074/jbc.M207781200

10.1095/biolreprod.104.029264

2005, Reproductive Biology, 5, 5

10.1262/jrd.09-214H

10.1016/S0024-3205(97)00883-7

10.1016/j.bbrc.2003.08.105

10.1152/ajplung.00361.2007

10.1007/s11130-010-0154-8

10.1124/jpet.110.171983

1998, Journal of Neurochemistry, 71, 1854, 10.1046/j.1471-4159.1998.71051854.x